Author: laynezfm58

FRANKFURT, Germany – Sept. 28, 2022 – PRLog — PARTEX today announced the acquisition of Assay.Works, a Contract Research Organization (CRO) providing premium high-throughput screening and in vitro validation services to Pharma and Biotech customers around the globe. This acquisition represents an important milestone in PARTEX’s ambition to build the first Digital Pharma platform that accelerates knowledge-driven, end-to-end development from data to drugs. The transaction is expected to formally close in October; financial details have not been disclosed. Assay.Works was founded in 2016 inheriting the legacy of a major Biopharma’s High-Throughput Screening (HTS) Center located in the BioPark Regensburg, Germany. ... Read more